| The role of hippocampus in anxiety: intracerebral infusion studies E Engin, D Treit Behavioural pharmacology 18 (5-6), 365-374, 2007 | 301 | 2007 |
| Anxiolytic-and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models E Engin, D Treit, CT Dickson Neuroscience 161 (2), 359-369, 2009 | 196 | 2009 |
| An emerging circuit pharmacology of GABAA receptors E Engin, RS Benham, U Rudolph Trends in pharmacological sciences 39 (8), 710-732, 2018 | 184 | 2018 |
| Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence E Engin, J Stellbrink, D Treit, CT Dickson Neuroscience 157 (3), 666-676, 2008 | 139 | 2008 |
| α2-containing GABAA receptors: A target for the development of novel treatment strategies for CNS disorders E Engin, J Liu, U Rudolph Pharmacology & therapeutics 136 (2), 142-152, 2012 | 119 | 2012 |
| Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice KS Smith, E Engin, EG Meloni, U Rudolph Neuropharmacology 63 (2), 250-258, 2012 | 107 | 2012 |
| Decreased anxiety-like behavior and Gαq/11-dependent responses in the amygdala of mice lacking TRPC4 channels A Riccio, Y Li, E Tsvetkov, S Gapon, GL Yao, KS Smith, E Engin, ... Journal of Neuroscience 34 (10), 3653-3667, 2014 | 103 | 2014 |
| The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus E Engin, D Treit Behavioural pharmacology 18 (5-6), 461-470, 2007 | 103 | 2007 |
| Tonic inhibitory control of dentate gyrus granule cells by α5-containing GABAA receptors reduces memory interference E Engin, ED Zarnowska, D Benke, E Tsvetkov, M Sigal, R Keist, ... Journal of Neuroscience 35 (40), 13698-13712, 2015 | 86 | 2015 |
| Modulation of anxiety and fear via distinct intrahippocampal circuits E Engin, KS Smith, Y Gao, D Nagy, RA Foster, E Tsvetkov, R Keist, ... Elife 5, e14120, 2016 | 84 | 2016 |
| Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors E Engin, D Treit Psychopharmacology 206, 281-289, 2009 | 82 | 2009 |
| The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review E Engin, D Treit Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (6), 1399-1419, 2008 | 75 | 2008 |
| Differential roles of GABAA receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward LM Reynolds, E Engin, G Tantillo, HM Lau, JW Muschamp, WA Carlezon, ... Neuropsychopharmacology 37 (11), 2531-2540, 2012 | 65 | 2012 |
| Animal models of anxiety and anxiolytic drug action D Treit, E Engin, K McEown Behavioral neurobiology of anxiety and its treatment, 121-160, 2010 | 64 | 2010 |
| A pharmacogenetic ‘restriction-of-function’approach reveals evidence for anxiolytic-like actions mediated by α5-containing GABAA receptors in mice LM Behlke, RA Foster, J Liu, D Benke, RS Benham, AJ Nathanson, ... Neuropsychopharmacology 41 (10), 2492-2501, 2016 | 57 | 2016 |
| Etomidate impairs long-term potentiation in vitro by targeting α5-subunit containing GABAA receptors on nonpyramidal cells FC Rodgers, ED Zarnowska, KT Laha, E Engin, A Zeller, R Keist, ... Journal of Neuroscience 35 (26), 9707-9716, 2015 | 41 | 2015 |
| Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus E Engin, D Treit Neuropeptides 42 (4), 411-421, 2008 | 39 | 2008 |
| Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens E Engin, KI Bakhurin, KS Smith, RM Hines, LM Reynolds, W Tang, ... Neuropsychopharmacology 39 (8), 1805-1815, 2014 | 38 | 2014 |
| Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions M Yeung, E Engin, D Treit Psychopharmacology 216, 557-567, 2011 | 35 | 2011 |
| GABAA receptor subtypes and benzodiazepine use, misuse, and abuse E Engin Frontiers in Psychiatry 13, 1060949, 2023 | 28 | 2023 |
Uwe RudolphDept. of Comparative Biosciences, University of Illinois at Urbana-ChampaignVerified email at illinois.edu
